BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-22 out of 22 found
  Current Search:  dengue: 22     

HTML
100%
Trends in the epidemiology of dengue fever and their relevance for importation to Europe
Dengue fever continues to spread globally, causing major epidemics and putting major strain on health systems in affected countries.

For imported dengue in Europe, south east Asia is the most important region of origin, followed by...

Eurosurveillance:  Jun 26 2009 4:31AM
Matching: dengue
Find similar documents
HTML
100%
Co-infections with Chikungunya Virus and Dengue Virus in Delhi, India
_ Co-infections with Chikungunya Virus and Dengue Virus in Delhi, India.
Center for Disease Control and Prevention:  Jun 25 2009 5:45PM
Matching: dengue
Find similar documents
HTML
100%
NanoViricides, Inc. CEO Invited to Speak at NanoBio 2009 Conference
- NanoViricides, Inc.

(OTC BB: NNVC.OB) (the 'Company'), announced today that its CEO, Dr.

Eugene Seymour, has been invited to present a talk, and, in addition, participate in presenting a workshop on Nanoparticle Formulation: principles...

Pharma Live:  Jun 25 2009 3:35AM
Matching: dengue
Find similar documents
HTML
100%
World's First Tetravalent Dengue Vaccine in Clinical Trial
_ World's First Tetravalent Dengue Vaccine in Clinical Trial.
Asia-Pacific Biotech:  Jun 24 2009 5:09AM
Matching: dengue
Find similar documents
HTML
100%
Dengue maculopathy: visual electrophysiology and optical coherence tomography
Save in My Library Free Abstract Mendes TS et al.

- The dengue fever can lead to visual impairment detectable by ophthalmological exams such as angiography, retinography, and OCT imaging, as well as retinal and cortical electrophysiology....

MDLinx:  Jun 23 2009 10:30AM
Matching: dengue
Find similar documents
HTML
100%
NanoViricides, Inc. CEO Invited to Speak at NanoBio 2009 Conference
- NanoViricides, Inc.

(OTC BB: NNVC.OB) (the 'Company'), announced today that its CEO, Dr.

Eugene Seymour, has been invited to present a talk, and, in addition, participate in presenting a workshop on Nanoparticle Formulation: principles...

DiGiTAL50:  Jun 22 2009 1:17PM
Matching: dengue
Find similar documents
HTML
100%
NanoViricides, Inc. CEO Invited to Speak at NanoBio 2009 Conference
NanoViricides, Inc.

(OTC BB: NNVC.OB) (the 'Company'), announced today that its CEO, Dr.

Eugene Seymour, has been invited to present a talk, and, in addition, participate in presenting a workshop on Nanoparticle Formulation: principles...

Genetic Engineering News:  Jun 22 2009 12:31PM
Matching: dengue
Find similar documents
HTML
100%
DoctorsEUR Statements on the Dengue Epidemic
_ DoctorsEUR Statements on the Dengue Epidemic.
Malaysian Medical Resources:  Jun 12 2009 6:53PM
Matching: dengue
Find similar documents
HTML
100%
First climate-based biotechnology model of Dengue outbreaks
Dengue Fever (DF) and Dengue Hemorrhagic Fever (DHF) are the most important vector-borne viral diseases in the World.

Around 50-100 million cases appear each year putting 2.5 billion people at risk of suffering this...

Scientist Live:  Jun 11 2009 11:23AM
Matching: dengue
Find similar documents
HTML
100%
Philippines Health Secretary Warns Of Impending Dengue Threat
News Archive [link] Web Wikipedia Medical Dictionary [link] login | register Tropical Diseases News Main Category: Tropical Diseases email to a friend printer friendly view / write opinions rate article Current Article Ratings: Patient /...
Medical News Today:  Jun 11 2009 11:48AM
Matching: dengue
Find similar documents
HTML
100%
Dengue Fever - Researchers from Nanyang Technological University report details of new studies and findings in
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA We're a pay-per-view site for premium content.

If you'd like to purchase this article, it's only $3.00.

Dengue Fever Researchers from...

NewsRX:  Jun 9 2009 6:35PM
Matching: dengue
Find similar documents
HTML
100%
Scientists use climate variables and vegetation indices to predict and mitigate Dengue epidemics
Dengue Fever (DF) and Dengue Hemorrhagic Fever (DHF) are the most important vector-borne viral diseases in the World.

Around 50-100 million cases appear each year putting 2.5 billion people at risk of suffering this...

News-Medical.Net:  Jun 8 2009 3:12PM
Matching: dengue
Find similar documents
HTML
100%
climate-based Model to Predict Dengue Fever Outbreaks Developed
Dengue Fever (DF) and Dengue Hemorrhagic Fever (DHF) are the most important vector-borne viral diseases in the World.

Around 50-100 million cases appear each year putting 2.5 billion people at risk of suffering this...

Bioscience Technology Online:  Jun 8 2009 6:32PM
Matching: dengue
Find similar documents
HTML
100%
FDA Cites Diagnostics Maker for Several GMP Violations
IVD Research did not require its employees to conduct risk analyses or document design validations for several of its devices, according to an FDA warning letter.

The agency cited the company for failure to establish and maintain written...

FDA News:  May 29 2009 6:57PM
Matching: dengue
Find similar documents
HTML
100%
Flu A/H1N1 cases rise to 14 in Philippines
MANILA, May 29 (Xinhua) -- The Philippines has reported a total of 14 confirmed influenza A/H1N1 cases in the country following the confirmation of four more cases on Friday, according to the country's health department on Friday.

Two of...

Xinhua News Agency:  May 29 2009 10:34AM
Matching: dengue
Find similar documents
HTML
100%
NanoViricides, Inc. Announces Additional Herpes Keratitis Study
cases of HSV infection of the cornea in the US alone each year.

It is generally caused by HSV Type I.

Many of these cases lead to substantial scarring of the cornea and significantly reduced vision, which may necessitate corneal...

Pharma Live:  May 19 2009 12:12PM
Matching: dengue
Find similar documents
HTML
100%
Govt need to initiate research for developing anti viral drugs: Dr Rajarajan
Increasing thrust should be given to discovery and development of anti-viral drugs as the world is threatened with frequent outbreaks of viral diseases.

New generation of anti-viral drug is the need of the hour.

India is short of anti...

PharmaBiz:  May 16 2009 3:06AM
Matching: dengue
Find similar documents
HTML
100%
Sanofi-aventis to build new vaccine facility in France with Euro 350 mn
Sanofi-aventis, the world's leading vaccine manufacturer, officially launched the construction of a new Sanofi Pasteur vaccine manufacturing centre in Neuville-sur-Sane, France.

The investment in this new vaccine production facility in...

PharmaBiz:  May 13 2009 5:58AM
Matching: dengue
Find similar documents
HTML
100%
New Understanding of Dengue Virus Points Way to Possible Therapies for Dengue Fever
Dengue fever is a mosquito-borne disease that's becoming more of a problem around the world.

The range of dengue-carrying mosquitoes has spread from tropical into sub-tropical areas.

And some countries have had ongoing dengue...

VOA News:  May 7 2009 6:39PM
Matching: dengue
Find similar documents
HTML
100%
Fincor (FINC) Makes a Share Transfer and Enters the Market With ACTRx a New Malaria and Dengue Fever Treatment
/PRNewswire-FirstCall/ -- Fincor, acquired a majority of ACTRx International Inc., which combines several natural drugs to fight Malaria and Dengue fever and looks to become a premier global supplier of Malaria and Dengue cures,...
Pharma Live:  May 1 2009 9:44PM
Matching: dengue
Find similar documents
HTML
100%
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and
Pharmaceutical Patents Title: United States Patent: 7,517,531 Issued: April 14, 2009 Whitehead; Stephen S.

(Montgomery Village, MD), Murphy; Brian R.

(Bethesda, MD), Markoff; Lewis (Bethesda, MD), Falgout; Barry (Rockville, MD), Blaney;...

PharmCast:  Apr 28 2009 11:59AM
Matching: dengue
Find similar documents
HTML
100%
Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded to Singapore and Vietnam
SINGAPORE, April 21 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT : SAN and NYSE : SNY), announced today the start of clinical studies of its investigational tetravalent dengue vaccine in Singapore...
PR Newswire via Yahoo!:  Apr 21 2009 7:12AM
Matching: dengue
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.